JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Recruiting now · Phase 3

Conditions studied: Non-Small Cell Lung Cancer

In brief

To Determine if SAbR improves survival over SR in High Risk Operable Stage I NSCLC

Key facts

Study ID
NCT02468024
Run by
University of Texas Southwestern Medical Center
People needed
272
Starts
2015-07-01
Expected to finish
2028-12-01
Last updated by the study team
2026-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.